Skip to main content
. 2020 May 30;23(4):388–393. doi: 10.1007/s10047-020-01179-8

Table 1.

Patients’ characteristics at admission, during ICU stay and at follow-up

Case 1 Case 2 Case 3 Case 4 Case 5 Case6
Age, years 35 48 56 62 43 62
Sex Male Male Male Male Male Male
Premorbid condition

Cocaine

Tobacco

Type II diabetes mellitus

Tobacco

Coronary heart disease

Tobacco

Ischemic dilated cardiomyopathy

None Ischemic dilated cardiomyopathy
Reason for VA-ECMO Refractory cardiac arrest (cocaine-induced vasospasm) Septic cardiomyopathy Ischemic cardiogenic shock Primary heart graft dysfunction Ischemic cardiogenic shock Cardiogenic shock
Pre-ECMO SAPS II score 64 86 84 52 85 34
Pre-ECMO SOFA score 14 17 16 16 9 10
Duration of VA-ECMO support, days 4 29 2 47 4 13
Survival to hospital discharge Yes Yes Yes No Yes Yes
ICU length of stay (days) 90 74 6 51 9 30
Organ support during ICU stay
 Renal replacement therapy Yes Yes No Yes Yes No
 Mechanical ventilation duration (days) 78 51 3 51 8 1
ECMO cannulation site Femoral Femoral Femoral Femoral Femoral Femoral
ECMO flow rate at initiation (L/min) 4.23 3.9 4 3.8 3.1 4.1
IABP No No No No Yes Yes
Coronary angiography before SCI Yes Yes Yes No Yes No
 Localization (artery) Radial Femoral Femoral NK
Critical illness polyneuropathy at sedation withdrawal that could have delayed SCI diagnosis Yes Yes No Yes No No
Delay between awakening and SCI diagnosis (days) 36 48 0 33 0 NA*
Biology at ECMO start
 pH 7.23 7.26 7.50 7.20 6.87 7.63
 PaCO2, mmHg 23.5 31.8 31.3 33 70 31.8
 PaO2, mmHg 375 73 68.8 142 40 61.7
 Lactate, mmol/L 4.4 9 0.9 12.5 15 1
 Platelets count, 109/mL 234 45 73 260 100 51
 APTT (patient/reference) ratio 1.9 1.2 1.7 1,7 ND 2.48
 Prothrombin time, % 66 30 65 46 50 76
 Fibrinogen, g/L 2.4 5.8 5.5 1.8 1.8 5.6
Biology at SCI diagnosis
pH 7.51 7.46 7.49 7.49 7.4 ND
 PaCO2, mmHg 76.8 43.6 35.8 27.1 37 ND
 PaO2, mmHg 41.3 40 129 70 90 ND
 Lactate, mmol/L 1.9 1.2 0.9 1.6 1.5 ND
 Platelets, 109/mL 442 347 168 69 259 212
 APTT (patient/reference) ratio 2 1.3 1 1.17 1.7 1.6
 Prothrombin time, % 57 78 87 76 80 60
 Fibrinogen, g/L 7.4 7 7.8 3.6 4 4.3
- year follow-up Wheelchair urinary tract self-catheterization Wheelchair urinary tract self-catheterization Wheelchair urinary tract self-catheterization NA Wheelchair Pain in the lower limbs

Patient was always awake without sedation

ICU intensive care unit, VA-ECMO venoarterial-extracorporeal membrane oxygenation, SAPS simplified acute physiology score, SOFA sequential organ-failure assessment, SCI spinal cord infarction, IABP intra-aortic balloon counterpulsation, APTT activated partial thrombin time, NA not applicable, NK not known